Anixa Biosciences, Inc.
ANIX
$2.79
$0.176.49%
NASDAQ
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.94% | -6.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.54% | -5.56% | |||
| Operating Income | 2.54% | 5.56% | |||
| Income Before Tax | 1.90% | 5.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.90% | 5.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -25.93% | |||
| Net Income | 1.91% | 4.82% | |||
| EBIT | 2.54% | 5.56% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 2.98% | 5.62% | |||
| Normalized Basic EPS | 2.92% | 5.51% | |||
| EPS Diluted | 2.98% | 5.62% | |||
| Normalized Diluted EPS | 2.92% | 5.51% | |||
| Average Basic Shares Outstanding | 1.06% | 0.92% | |||
| Average Diluted Shares Outstanding | 1.06% | 0.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||